HomeBUSINESS
BUSINESS

Sanofi Files Spiramycin for Congenital Toxoplasmosis
(Oct.6.2017)

Sanofi said on October 5 that it filed on the same day a new drug application (NDA) with the Ministry of Health, Labor and Welfare (MHLW) for its macrolide antibiotic spiramycin for the prevention of prenatal congenital toxoplasmosis ...
(LOG IN FOR FULL STORY)

News Calendar